Hanson McClain Advisors »

Silverback Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Silverback Therapeutics

May 2024Jul 2024Sep 2024Nov 2024Jan 20255k10k200400600
Value ($)Share countHistorical SPRY position of Hanson McClain Advisors Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $10k 743 13.55
2024-09-30 $11k 743 14.50
2024-06-30 $865 82 10.55
2024-03-31 $838 82 10.23

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Us Treas Bd Etf (GOVT)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)
Apple (AAPL)
2023 Etf Series Trust Ii Gmo Us Quality E (QLTY)
Ishares Tr Usd Inv Grde Etf (USIG)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Ishares Tr Core S&p Ttl Stk (ITOT)
Invesco Exch Traded Fd Tr Ii S&p 500 Revenue (RWL)

View all positions for Hanson McClain Advisors

Top funds holding Silverback Therapeutics

RA Capital Management
Deerfield Management Company
OrbiMed Advisors
BlackRock
Sr One Capital Management
Alliancebernstein
Vanguard Group
State Street Corporation
Franklin Resources
Alyeska Investment Group
Geode Capital Management
Woodline Partners
Nextech Invest
FMR
Citadel Advisors

View all funds holding Silverback Therapeutics